Hayward Holdings HAYW 深 沪
等待开盘 09-27 09:30:00 美东时间
14.85
+0.310
+2.13%
华盛通- 最 高14.925
- 今 开14.64
- 成交量 177.02万股
- 最 低 14.64
- 昨 收 14.54
- 总市值 32.22亿
- 52周最高 16.87
- 市盈率 静 27.71
- 换手率 0.82%
- 52周最低 11.10
- 委 比 -32.06%
- 总股本 2.17亿
- 历史最高 28.65
- 量 比 0.34
- 振 幅 1.96%
- 历史最低 7.97
- 每 手 1
- 风险率 1.06%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Amazon's Zoox Seeks US Approval To Put 2,500 Fully Driverless Robotaxis On The Road
Amazon's self-driving unit Zoox seeks clearance to deploy driverless cars, competing with Tesla and Waymo. It plans to launch in Vegas and expand to San Francisco, Miami, and Austin.
09-25 01:29
Amazon's Zoox Debuts Free Robotaxi Rides On Las Vegas Strip, Challenging Tesla And Waymo
Amazon's Zoox debuts fully driverless robotaxi rides in Las Vegas, expanding its next-gen transportation service.
09-11 16:03
彻底翻身了！全球债市正式踏入牛市 国债依然“拖后腿”……
①随着固收市场全面回暖，追踪发达市场和新兴市场主权及公司债回报率的彭博全球综合债券指数已从2022年低点飙升了逾20%； ②这不仅刷新了2022年3月以来的最高水平，也正式宣告重返了技术性牛市区域。
09-10 08:25
Stifel Maintains Buy on Hayward Holdings, Raises Price Target to $18
Stifel analyst W. Andrew Carter maintains Hayward Holdings (NYSE:HAYW) with a Buy and raises the price target from $17.5 to $18.
09-05 20:09
Avingtrans Secures $16M Nuclear Contracts with South Korea
An announcement from Avingtrans ( ($GB:AVG) ) is now available. Avingtrans’ US-...
09-02 14:20
雷蒙德・梅森逝世享年88岁 执掌美盛集团46年
雷蒙德・梅森（Raymond Mason）逝世，享年 88 岁。在四十余年的职业生涯中，他通过一系列并购交易将美盛集团（Legg Mason Inc．）打造...
08-25 18:24
Ultra Clean Names Chris Cook as Chief Business Officer
HAYWARD, Calif., Aug. 6, 2025 /PRNewswire/ -- Ultra Clean Holdings, Inc. (Nasdaq: UCTT), announced today that its Board of Directors has appointed Chris Cook as Chief Business Officer of UCT...
08-07 11:01
Ultra Clean Announces Participation at Upcoming Investor Conferences
HAYWARD, Calif., Aug. 4, 2025 /PRNewswire/ -- Ultra Clean Holdings, Inc. (Nasdaq: UCTT), today announced its participation at two upcoming virtual investor conferences: August 13, 2025: Oppe...
08-04 20:30
Benitec Biopharma Receives Green Light To Advance BB-301 Trial After Safety Review; Cohort 2 Enrollment Set For Q4 2025
-In April 2025 the Sixth and Final Subject of Cohort 1 was Safely Treated with the Low Dose of BB-301 in the Phase 1b/2a Clinical Treatment Study (NCT06185673)--Independent Data Safety Monitoring Board Review Has Been
07-09 20:18
Applied DNA Sciences regains Nasdaq compliance
Applied DNA Sciences (NASDAQ:APDN) announced on Monday that it received a Nasdaq notice informing that the company has regained compliance with Nasdaq's minimum bid price requirement rule of $1.00 per...
07-07 21:19
